Publications
Original Article
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes
T Cell Function & Therapy
2021
Authors:
Schroeder BA, LaFranzo NA, LaFleur BJ, Gittelman RM, Vignali M, Zhang S, Flanagan KC, Rytlewski J, Riolobos L, Schulte BC, Kim TS, Chen E, Smythe KS, Wagner MJ, Mantilla JG, Campbell JS, Pierce RH, Jones RL, Cranmer LD, Pollack SM
Journal:
Journal for ImmunoTherapy of Cancer
Volume:
9(8)
Page:
Pubmed:
Original Article
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways
Cancer Vaccines
2021
Authors:
Cecil, D., Park, K H, Curtis, B, Corulli, L, and Disis, ML
Journal:
Journal for Immunotherapy of Cancer
Volume:
9
Page:
Pubmed:
Original Article
Association Between Plasma Diacetylspermine and Tumor Spermine Synthase With Outcome in Triple-Negative Breast Cancer
General Immune Research
2020
Authors:
Fahrmann JF, Vykoukal J, Fleury A, Tripathi S, Dennison JB, Murage E, Wang P, Yu CY, Capello M, Creighton CJ, Do KA, Long JP, Irajizad E, Peterson C, Katayama H, Disis ML, Arun B, Hanash S.
Journal:
Journal of Natural Cancer Institute
Volume:
112(6)
Page:
607-616
Pubmed:
Original Article
Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers
Tumor Microenvironment
2020
Authors:
Disis ML, Corulli LR, Gad EA, Koehnlein MR, Cecil DL, Senter PD, Gardai SJ, Okeley NM.
Journal:
Molecular Cancer theraputics
Volume:
19(5)
Page:
1102-1109
Pubmed:
Original Article
The Effect of Mouse Strain, Sex, and Carcinogen Dose on Toxicity and the Development of Lung Dysplasia and Squamous Cell Carcinomas in Mice
Animal Models
2019
Authors:
Laura Riolobos, Ekram A. Gad, Piper M. Treuting, Andrew E. Timms, Elliot A. Hershberg, Lauren R. Corulli, Erin Rodmaker and Mary L. Disis
Journal:
Cancer Prevention Research
Volume:
12(8)
Page:
507-16
Pubmed:
Original Article
A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancer
General Immune Research
2019
Authors:
Katayama H, Tsou P, Kobayashi M, Capello M, Wang H, Esteva F, Disis ML, Hanash S.
Journal:
NPJ Precision Oncology
Volume:
3
Page:
10
Pubmed:
Original Article
Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets
Cancer Vaccines
2019
Authors:
Stanton SE, Gad E, Corulli LR, Lu H, Disis ML.
Journal:
Vaccine
Volume:
37(27)
Page:
3552-3561
Pubmed:
Original Article
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial
Clinical Trials
2019
Authors:
Disis ML, Taylor MH, Kelly K, Beck JT, Gordon M, Moore KM, Patel MR, Chaves J, Park H, Mita AC, Hamilton EP, Annunziata CM, Grote HJ, von Heydebreck A, Grewal J, Chand V, Gulley JL.
Journal:
Jama Oncology
Volume:
5(3)
Page:
393-401
Pubmed:
Original Article
TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells
T Cell Function & Therapy
2018
Authors:
Dang Y, Rutnam ZJ, Dietsch G, Lu H, Yang Y, Hershberg R, Disis ML.
Journal:
Journal Leukucyte Biology
Volume:
103(1)
Page:
157-164
Pubmed:
Original Article
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
Clinical Trials
2018
Authors:
Miller JS, Morishima C, McNeel DG, Patel MR, Kohrt HEK, Thompson JA, Sondel PM, Wakelee HA, Disis ML, Kaiser JC, Cheever MA, Streicher H, Creekmore SP, Waldmann TA, Conlon KC.
Journal:
Clinical Cancer Research
Volume:
24(7)
Page:
1525-1535
Pubmed: